| Stereochemistry | RACEMIC |
| Molecular Formula | C19H17ClN2O4 |
| Molecular Weight | 372.802 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCC(O)COC(=O)C1=CC=CC=C1NC2=C3C=CC(Cl)=CC3=NC=C2
InChI
InChIKey=GWOFUCIGLDBNKM-UHFFFAOYSA-N
InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)
Approval Year
PubMed
Patents
Sample Use Guides
human aortic smooth muscle cells (haSMCs) and human endothelial cells (ECs) were seeded in tissue culture flasks. The cells were treated for 4 days with glafenine hydrochloride (10 uM, 50 uM, 100 uM). Half of the treated groups were incubated again with glafenine hydrochloride, the other half received medium free of glafenine hydrochloride every 4 days until day 20.
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
